Membrane-type 1 matrix metalloproteinase (MT1-MMP) is an integral membrane proteinase that performs processing of cell surface proteins and degradation of extracellular matrix (ECM) components. Through these proteolytic events, MT1-MMP regulates various cellular functions, including ECM turnover, promotion of cell migration and invasion, and morphogenic responses to extracellular stimuli. MT1-MMP has to be regulated strictly to accomplish its function appropriately at various steps, including at the transcriptional and post-translational levels. MT1-MMP was originally identified as an invasion-promoting enzyme expressed in malignant tumour cells, and also as a specific activator of proMMP-2, which is believed to play a role in invasion of the basement membrane. Since then, it has attracted attention as a membrane-associated MMP that promotes cancer cell invasion and angiogenesis by endothelial cells. Although MT1-MMP has now become one of the best characterized enzymes in the MMP family, there remain numerous unanswered questions. In this chapter, we summarize our recent findings on how MT1-MMP is regulated during cell migration, and how cell migration is regulated by MT1-MMP.
Introduction
Membrane-type 1 matrix metalloproteinase (MT1-MMP; also known as MMP-14) was the first MT-MMP to be identified as an activator of proMMP-2 on the surface of cancer cells [1] . Another five MT-MMPs have since been iden-tified: MT2-MMP (MMP-15) [2] , MT3-MMP (MMP-16) [3] , MT4-MMP (MMP-17) [4, 5] , MT5-MMP (MMP-24) [6, 7] and MT6-MMP (MMP-25) [8, 9] . Among the six MT-MMPs, MT1-MMP is most frequently expressed in human tumours, and has the ability to promote invasion and metastasis when expressed in cancer cells [10] .
To promote cancer invasion, MT1-MMP has to degrade the extracellular matrix (ECM) barrier. MT1-MMP can digest fibronectin, vitronectin, laminin-1, laminin-5, fibrin and dermatan sulphate proteoglycans [11] [12] [13] [14] [15] . The enzyme also degrades gelatin, casein and elastin [15] [16] [17] , and shows activity against collagen types I, II and III [14] . A deficiency of MT1-MMP in mice has emphasized the importance of the degradation of the ECM by MT1-MMP during development [18, 19] . The animals showed inadequate collagen turnover, resulting in dwarfism, osteopenia, arthritis and connective tissue disease.
MT1-MMP also co-operates with other MMPs to degrade complex ECM components. Most importantly, MT1-MMP activates proMMP-2 on the cell surface. As a first step, proMMP-2 binds to cells expressing MT1-MMP. However, MT1-MMP cannot bind proMMP-2 directly, but uses TIMP-2 (tissue inhibitor of metalloproteinases-2) as an adaptor molecule. In addition to an N-terminal inhibitory domain that binds to and inhibits the catalytic domains of MMPs, TIMP-2 has a C-terminal domain that has a specific ability to bind to the haemopexin-like (PEX) domain of MMP-2. Thus, after MT1-MMP is inhibited by TIMP-2, the complex provides a binding site for proMMP-2 on the cell surface [16, 20] . The proMMP-2 in the complex can then be activated by another MT1-MMP molecule adjacent to the complex [21, 22] . Thus the levels of TIMP-2 on the cell surface play a critical regulatory role in proMMP-2 activation. Without TIMP-2, MT1-MMP cannot mediate the activation, but an excess of TIMP-2 inhibits all of the activity of MT1-MMP, including the activation of proMMP-2 [21] . Although there appears to be a contradiction between the model in which TIMP-2 is required for MT1-MMP to activate proMMP-2 and the role of TIMP-2 as a general MMP inhibitor, there is genetic evidence that proMMP-2 is not activated efficiently in TIMP-2-deficient mice [23, 24] . Activation of proMMP-2 by cancer cells is presumably important for invasion of the basement membrane because of its type IV collagenase activity. In the type I collagen-rich environment in the stroma, MT1-MMP/MMP-2 can act as a potent type I collagen degradation system through a combination of the collagenase activity of MT1-MMP and the gelatinase activity of MMP-2. MT1-MMP can also activate proMMP-13 in a cell-mediated manner, and proMMP-9 indirectly [25] .
to aggregate [26] . Localization of MT1-MMP on the cell surface coincided exactly with the actin aggregates within the cells treated with the drug. Thus the localization of MT1-MMP seems to be regulated by dynamic remodelling of the actin cytoskeleton during cell locomotion. MT1-MMP has a short cytoplasmic tail, but this is not the site for actin association; unexpectedly, the PEX domain was found to be responsible for this association. Thus it was speculated that the association is mediated by another cell surface protein. CD44, a major hyaluronan receptor that associates with actin within cells, also localizes at the leading edge of migrating cells, and was identified as a linker that mediates the association of MT1-MMP with actin [26] (Figure 1 ). CD44 was co-immunoprecipitated with MT1-MMP, and this could be prevented by overexpression of the MT1-MMP PEX fragment, but not the catalytic fragment. Finally, the recombinant PEX fragment binds directly to CD44 polypeptide produced in Escherichia coli. The complex-forming ability of the two molecules correlated well with the localization of MT1-MMP to the ruffling edge. Deletion of the PEX domain of MT1-MMP abolished its localization at the leading edge, and overexpression of a mutant CD44 lacking the cytoplasmic portion also blocked the distribution of MT1-MMP to the edge. Thus CD44 plays a critical role in the regulation of the polarized distribution of MT1-MMP during cell migration and invasion, and of its association with the actin cytoskeleton.
Regulation of MT1-MMP activity at the leading edge
The activation of proMMP-2 requires at least two MT1-MMP molecules, and this is accomplished by the formation of a homophilic oligomer through the PEX domain [27, 28] (Figure 2 ). To detect the MT1-MMP oligomer in vivo, we prepared MT1-MMP tagged either with a FLAG epitope or with Myc peptide [27] . When the two molecules were co-expressed and immunoprecipitated using antibodies against one of the tags, the other MT1-MMP was associated with the precipitate, indicating that a homophilic complex had been formed. The PEX domain was again responsible for oligomer formation. As expected, formation of the oligomer was critical for the efficient activation of proMMP-2, because replacement of the PEX domain of MT1-MMP with that of MT4-MMP, which does not form a homo-oligomer, abolished the ability of MT1-MMP to activate proMMP-2. Interestingly, the chimaera containing the MT4-MMP PEX domain retained the ability to form a trimolecular complex of MT1-MMP, TIMP-2 and proMMP-2 on the cell surface.
How is the formation of such an oligomer regulated in relation to cell function? To visualize oligomer formation in situ, a chimaeric protein composed of the extracellular portion of MT1-MMP and the transmembrane and cytoplasmic portions of the nerve growth factor receptor (NGF-R) was constructed [27] . The binding of ligand to NGF-R is known to induce dimerization of the receptor and to cause autophosphorylation of the cytoplasmic tyrosine residues. Thus, if the MT1-MMP portion of the chimaera formed homo-oligomers, this would cause autophosphorylation of the NGF-R cytoplasmic portion. Co-expression of constitutively active Rac1 and the MT1-MMP/NGF-R chimaera in COS-1 cells induced the formation of lamellipodia, and the chimaera was found to localize at these sites with intense autophosphorylation signals. At the same time, the expression of active Rac1 enhanced the activation of proMMP-2 [27, 29] . Thus the ruffled edge that forms the migration front is likely to be the place for oligomer formation of MT1-MMP and activation of proMMP-2.
The cytoplasmic portion of MT1-MMP may play some role in the formation of the oligomer [28, 30] , although our chimaera that formed homo-oligomers lacked the cytoplasmic portion. It may modulate the localization of MT1-MMP in certain situations and eventually affect oligomer formation. Collagen binding to the PEX domain also modulates the efficiency of proMMP-2 activation [31] .
Internalization forms part of the mechanism of MT1-MMP turnover on the cell surface
After being expressed as an active enzyme on the cell surface and performing its function, MT1-MMP is inactivated either by binding to TIMPs or by proteolytic degradation. Cells expressing MT1-MMP at high levels frequently generate degradation fragments, of which major forms can be detected as bands in the range 43-45 kDa on SDS/PAGE [32] [33] [34] . This degradation is mainly caused by autocatalytic processing, and therefore such a pattern of degradation accurately reflects the active state of MT1-MMP on the cell surface, including its ability to activate proMMP-2. How are these molecules cleared from the surface and replaced by newly synthesized forms? MT1-MMP has a short cytoplasmic tail of 20 amino acids, and this portion was found to mediate internalization of the enzyme [35, 36] . The cytoplasmic tail has a binding site for the 2 subunit of adaptor protein 2 (AP2), which mediates incorporation of the target protein into a clathrin-coated pit for internalization [35] . Although internalization is not selective for inactivated MT1-MMP molecules, it is presumably an important part of the mechanism involved in MT1-MMP turnover. TIMP-2 has been reported to be internalized and degraded during activation of proMMP-2 [37] , and this process is also likely to be mediated by MT1-MMP internalization [35] .
Regulation of cell migration
Cellular invasion requires ECM degradation coupled with cell locomotion. MT1-MMP acts not only to eliminate the ECM barrier, but also to modulate the migratory behaviour of cells in multiple ways. We found that MT1-MMP binds CD44 and forms a complex at the leading edge [26] . CD44 is also processed by MT1-MMP accompanying promotion of cell migration [38] (Figure 1 ). Expression of a mutant CD44 that cannot be cleaved by MT1-MMP prevented the promotion of cell migration by MT1-MMP. Although the mechanism by which cell migration is promoted by MT1-MMP is not clear, processing of CD44 may regulate cell adhesion properties to the level appropriate for migration. Another scenario is that the processing generates signals to promote cell migration via CD44 itself or associated molecules. Indeed, activa-tion of extracellular-signal-regulated kinase (ERK) is observed when cell migration is induced by MT1-MMP [39] . The cytoplasmic portion of the processed CD44 is reported to translocate into the nucleus after additional processing, and acts as a transcription factor by binding to the regulatory regions of genes [40] . Targets of transcriptional activation by the cytoplasmic tail of CD44 may include genes encoding migration-related proteins.
Laminin-5, a major component of the basement membrane, is known to support the migration of various types of cells, including tumour cells. MMP-2 was shown to cleave the ␥2 chain of laminin-5 and to promote the migration of breast epithelial cells [41] . Subsequently, cells constitutively motile on laminin-5 were found to express MT1-MMP rather than MMP-2 [12] . Antisense oligonucleotides against the MT1-MMP gene inhibited both processing of the ␥2 chain of laminin-5 and cell migration. Thus cleavage of the ␥2 chain by MT1-MMP appears to convert it from an inactive into an active form as regards the promotion of migration, presumably exposing a new functional domain that is cryptic before processing. This system might support the sustained locomotion of tumour cells that express both MT1-MMP and the laminin-5 ␥2 chain.
Integrins also form a well known adhesion system for cell migration [42] . Integrin ␣v␤3, which binds to vitronectin, is expressed in endothelial cells and invasive tumour cells. The ␣v chain, which is translated as a single polypeptide and converted into a two-chain form by protein convertases, is processed alternatively by MT1-MMP into a functional form [43] . The expression of integrin ␣v␤3 and MT1-MMP in human breast carcinoma MCF-7 cells did not alter adhesion to vitronectin, but stimulated migration on the matrix accompanying phosphorylation of focal adhesion kinase [44] . Additionally, the cell surface tissue transglutaminase that associates with the integrin ␤1 or ␤3 chain is also cleaved at multiple sites by MT1-MMP [45] . Tissue transglutaminase binds to fibronectin as a co-receptor of integrins, and cleavage of the transglutaminase by MT1-MMP suppressed cell adhesion to fibronectin and migration. On the other hand, MT1-MMP promoted migration of the same cells on type I collagen [45] .
Invasion-promoting activity of MT1-MMP
Expression of MT1-MMP in cancer cells enhances their invasive and metastatic potential [1, 46] . Cancer cell lines that express MT1-MMP constitutively are in general more invasive than non-MT1-MMP-producing cells [10, 47] .
In type I collagen gels, MDCK cells form a tubular structure in response to hepatocyte growth factor. Induced expression of MT1-MMP in the collagen gel plays a critical role in the tubule formation that requires invasion of the gel, because an antisense oligonucleotide to MT1-MMP abolished the response almost completely [48] . However, the expression of excess amounts of MT1-MMP in MDCK cells strongly enhanced their invasive properties and disturbed tubule formation [49] . In contrast, secreted MMPs, including the collagen-degrading MMP-1 and a soluble form of a MT1-MMP mutant, failed to promote invasion [49] . Thus membrane anchoring appears to be crucial in MT1-MMP and cell migration  259 order for MT1-MMP to promote invasion, and excessive invasion hampers the morphogenic response to hepatocyte growth factor. In addition its catalytic activity, other domains of MT1-MMP also regulate invasion-promoting activity. One such domain is the PEX domain, which is responsible for the formation of a homo-oligomer and binding to CD44. Overexpression of the PEX domain, which anchors to the plasma membrane, inhibited activation of proMMP-2 and the invasion of HT1080 cells into Matrigel [27] . The PEX domain also has collagen binding activity, and overexpression of a PEX domain fragment together with the linker sequence strongly inhibited collagenolysis and collagen-induced proMMP-2 activation by MT1-MMP [31] . The cytoplasmic tail of MT1-MMP is also indispensable for its invasion-promoting activity in Matrigel [35, 50] , but not in collagen gels [49] . Interestingly, mutations in the cytoplasmic tail that abolished this activity of MT1-MMP coincided with those that impaired internalization [35] . These mutant enzymes retain proteolytic activity on the cell surface at a level comparable with that of wild-type MT1-MMP. Excessive accumulation of inactivated MT1-MMP at the leading edge of invading cells may hamper the normal function of MT1-MMP there. It is also possible that an important functional region in the regulation of invasion overlaps with the motif for internalization, because there are possible sites for phosphorylation and lipid modification close to this motif.
Conclusions
MT1-MMP is a potent ECM-degrading enzyme that forms part of the invasion machinery of cancer cells. In this regard, MT1-MMP has to be closely regulated in order to co-operate with other components of the invasion-related machinery so it can accomplish its roles appropriately. For example, MT1-MMP is delivered to the leading edge of migratory cells to open up the route of invasion, and once there it assembles other MMPs with different substrate specificities to degrade complex ECM components in the basement membrane and in the stroma. MT1-MMP also modulates the migratory properties of cells by carrying out the functional conversion of target molecules such as CD44, integrin ␣v chain, tissue transglutaminase and laminin-5 ␥2chain. Thus the complex roles of MT1-MMP and its regulation during cancer invasion are now becoming clear. These regulatory steps represent targets in developing strategies for cancer therapy.
